The EU helps to improve public health though funding and legislation on a wide range of topics, such as food, diseases, clean air and more.
Why health policies are needed at EU level
National goverments are primarily responsible for organising and delivering healthcare and social security. The EU's role is to complement and support member states in improving the health of Europeans, reducing health inequalities and moving towards a more social Europe.
Labour market developments and the free movement of people and goods in the internal market necessitate the coordination of public health issues. EU public health policy has helped countries pool resources and tackle common challenges such as antimicrobial resistance, preventable chronic diseases and an aging population.
The EU issues recommendations and has laws and standards to protect people, covering health products and services (such as pharmaceuticals, medical devices, eHealth), and patients (rules on patients' rights in cross-border healthcare).
EU Health Programme
The work is funded through the EU Health Programme, which encourages cooperation and promotes strategies for good health and healthcare.
The current health programme covers 2014-2020 and has a €450 million budget. Its aims are to:
- promote healthy lifestyles
- protect people in the EU from serious cross-border health threats
- facilitate access to high-quality and safe healthcare
- contribute to sustainable health systems
Health-related funding will be integrated into the European Social Fund Plus (ESF+) in the next EU long-term budget for 2021-2027.
These specialised EU agencies work to ensure better health and healthier and safer workplaces
Medicines and medical devices
The EU regulates the authorisation and classification of medicines through the European medicines regulatory network, a partnership between the European Medicines Agency, national regulators and the European Commission. Once on the market, the safety of authorised products continues to be monitored.
There are specific EU rules covering medicines for children, rare diseases, advanced therapy products and clinical trials. The EU also has rules to fight falsified medicines and to ensure that the trade in medicines is controlled.
New rules on medical devices and in vitro diagnostic medical devices, such as heart valves or laboratory equipment, were adopted by MEPs in 2017 to keep up with scientific progress, improve safety and ensure better transparency.
As rules on the use of medical cannabis vary widely among EU countries, Parliament called for an EU-wide approach and properly funded scientific research in 2019.
Healthcare when abroad
The European Health Insurance Card (EHIC) ensures that people living in the EU can have access to medically necessary, state-provided healthcare during a temporary stay - whether a business trip, holiday, or a study abroad - in all EU countries, Iceland, Liechtenstein, Norway and Switzerland. Necessary healthcare should be provided under the same conditions and at the same cost (free in some countries) as people insured in that country.
Promoting health and tackling diseases
The EU works to promote health and prevent diseases in areas such as cancer, mental health and rare diseases, and provides information on diseases via the European Centre for Disease Prevention and Control (ECDC).
Tobacco consumption is responsible for nearly 700,000 deaths every year in the EU. The updated EU tobacco directive, aiming to make tobacco products less attractive for young people, became applicable in 2016. The Council recommendation on smoke-free environments of 2009 calls on EU countries to protect people from being exposed to tobacco smoke in public places and at work.
About 30 million Europeans are affected by rare and complex diseases. To help with diagnoses and therapies, the EU set up the European Reference Networks (ERNs) in 2017. The 24 existing virtual networks bring together specialists from different countries working on different issues, for example on patient safety or prevention of antimicrobial resistance.
Antimicrobial resistance (AMR) is on the rise, due to the overuse of antibiotics, improper disposal of medicines or the lack of development of new substances. It causes about 33,000 deaths per year in the EU. The EU’s 2017 action plan against antimicrobial resistance aims to promote awareness and better hygiene as well as stimulate research. A new regulation on veterinary medicinal products was adopted in 2018, to curb the use of antibiotics in farming and halt the spread of resistances from animals to humans.
Several EU countries are facing outbreaks of vaccine-preventable diseases such as measles, due to insufficient vaccination coverage rates. In a resolution adopted in 2018, MEPs call for a better aligned schedule for vaccination across Europe, more transparency in the production of vaccines and joint purchases to reduce prices.
Cleaner air, cleaner water
Poor air quality is the number one environmental cause of premature death in Europe. Since the early 1970s, the EU has taken action to control emissions of harmful substances. In 2016 a new directive was adopted setting tougher national emission limits for key air pollutants, such as nitrogen oxides, to halve their impact on health compared to 2005.
The Water Framework Directive protects EU waters and concerns all ground and surface waters, including rivers, lakes and coastal waters.
Bathing waters are monitored for bacteria by EU countriesthrough the bathing water directive. The EU is also updating its drinking water directive to further improve the quality of drinking water as well as access to it while also reducing waste caused by the consumption of bottled water.
There are specific hygiene rules for:
- food of animal origin
- food contamination (setting maximum levels for contaminants such as nitrates, heavy metals or dioxins)
- novel foods (produced from micro-organisms or with a new primary molecular structure)
- food contact materials (such as packaging materials and tableware).
The EU also has a strict legal framework for the cultivation and commercialisation of genetically modified organisms (GMOs) used in feed and food. The European Parliament is particularly attentive to potential health risks and has opposed plans for the authorisation of new genetically modified plants such as soybeans.
In 2019, MEPs adopted a report on how to improve the sustainable use of pesticides and backed the report of its special committee advocating more transparent authorisation procedures.
With more consumers buying organic food, the EU updated its rules on organic farming in 2018 to have stricter controls and better prevention of contamination.
EU legislation sets minimum health and safety requirements to protect you in the workplace, whilst allowing member states to apply stricter provisions. There are specific provisions on the use of equipment, the protection of pregnant and young workers and the exposure to noise or specific substances, such as carcinogens and mutagens.
Europe’s ageing workforce and increasing retirement age create challenges for the health care system. In 2018, MEPs adopted measures to retain and reintegrate workers with injuries or chronic health problems into the workplace. This included making workplaces more adaptable through skills development programmes, ensuring flexible working conditions and providing support to workers, including coaching and providing access to a psychologist or therapist.
To ensure people with disabilities participate fully in society, Parliament approved the European Accessibility Act in 2019. The new rules aim to ensure everyday products and key services - such as smartphones, computers, e-books, ticketing, check-in machines and ATMs - are accessible to elderly people and people with disabilities across the EU.
Find out more about EU social policies